PDF(Pubmed)
Abstract：
Stroke is one of the leading causes of morbidity and mortality worldwide. As the number of stroke cases is rising from one year to another, policymakers require data on the amount spent on stroke to enforce better financing policies for prevention, hospital care, outpatient rehabilitation services and social services. We aimed to systematically assess the economic burden of stroke at global level. Cost of stroke studies were retrieved from five databases. We retrieved the average cost per patient, where specified, or estimated it using a top-down approach. Resulting costs were grouped in two main categories: per patient per year and per patient lifetime. We extracted information from forty-six cost of illness studies. Per patient per year costs are larger in high income countries and in studies conducted from the payer perspective. The highest average per patient per year cost by country was reported in the United States ($59,900), followed by Sweden ($52,725) and Spain ($41,950). The highest per patient lifetime costs were reported in Australia ($232,100) for all identified definitions of stroke. Existing literature regarding the economic burden of stroke is concentrated in high-income settings, with very few studies conducted in South America and Africa. Published manuscripts on this topic highlight substantial methodological heterogeneity, rendering comparisons difficult or impossible, even within the same country or among studies with similar costing perspectives.
摘要：
中风是世界范围内发病率和死亡率的主要原因之一。随着中风病例的数量从一年增加到另一年，政策制定者需要中风支出的数据，以实施更好的预防融资政策，医院护理,门诊康复服务和社会服务。我们旨在在全球范围内系统地评估中风的经济负担。从五个数据库中检索中风研究的成本。我们检索了每位患者的平均费用，在指定的地方，或者用自上而下的方法估计。由此产生的费用分为两大类：每位患者每年和每位患者一生。我们从46项疾病成本研究中提取了信息。在高收入国家和从付款人角度进行的研究中，每位患者每年的费用更高。按国家分列的每位患者每年平均费用最高的国家是在美国（59,900美元），其次是瑞典（52,725美元）和西班牙（41,950美元）。在澳大利亚，所有已确定的中风定义中，每位患者的终生费用最高（232,100美元）。关于中风经济负担的现有文献集中在高收入环境中，在南美和非洲进行的研究很少。关于这一主题的已发表手稿强调了实质性的方法论异质性，渲染比较困难或不可能，即使在同一国家或具有相似成本计算观点的研究中也是如此。
